Acurable is a venture-backed medical technology company focused on developing and commercializing novel wearable medical devices to be used by patients as they go about their daily lives. Their award-winning, patented AcuPebble® technology is a breakthrough in home-based medical diagnostics and monitoring for respiratory conditions, particularly sleep apnea. AcuPebble sensors detect physiological acoustic signals from the body, enabling automated, accurate, and non-invasive assessment. The company aims to simplify complex diagnostic pathways, making healthcare more accessible, affordable, and patient-centric.
The London headquarters serves as the primary center for research and development, product engineering, clinical validation, global strategy, and corporate operations.
Situated within the Imperial College White City Incubator, providing access to cutting-edge lab facilities, a vibrant ecosystem of startups, and strong ties with academic research excellence.
Acurable fosters an innovative, collaborative, and fast-paced work environment. The culture emphasizes scientific rigor, patient impact, and a drive to solve complex healthcare challenges through technology.
Being in London provides Acurable with access to a rich talent pool, leading research institutions, and proximity to key European markets and regulatory bodies, crucial for its MedTech focus.
While headquartered in the UK with a key office in the USA, Acurable supports clinical studies and commercial activities across multiple regions. Its AcuPebble device has received CE mark for Europe and FDA 510(k) clearance for the USA, enabling its use in these major markets. The company is actively expanding its distribution networks and partnerships to make its technology available globally.
Imperial College White City Incubator, 80 Wood Lane
London
United Kingdom
Address: 1 Broadway, Cambridge, MA 02142, USA (Likely CIC Cambridge or similar shared innovation space)
To drive adoption of AcuPebble technology in the significant US healthcare market, manage FDA compliance, and build relationships with US-based clinicians, distributors, and strategic partners.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Acurable' leadership includes:
Acurable has been backed by several prominent investors over the years, including:
Acurable has made strategic additions to its executive team over the past 12-18 months to bolster its commercial, financial, and medical leadership as it scales its operations and expands market reach.
Discover the tools Acurable uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Acurable likely utilizes common professional email formats. Based on industry standards and observed patterns for similar MedTech companies, the most common format is typically [first_initial][last]@[companydomain.com] or [first].[last]@[companydomain.com].
[first_initial][last]@acurable.com (e.g., jdoe@acurable.com) or [first].[last]@acurable.com (e.g., jane.doe@acurable.com)
Format
erodriguezvillegas@acurable.com
Example
80%
Success rate
MobiHealthNews • July 19, 2023
Acurable, the UK-based company behind the AcuPebble home sleep apnea test, scored £9.5 million ($11.7 million) in Series A funding. The round was led by KHP MedTech Innovations and Calculus Capital. The funds will be used to accelerate the international expansion of its AcuPebble SA100 device....more
PR Newswire • May 24, 2023
Acurable, a London-based, award-winning medical device company, today announced that its AcuPebble SA100 wearable medical device has received 510(k) clearance from the U.S. Food and Drug Administration (FDA). This clearance allows Acurable to market AcuPebble SA100 in the United States....more
Acurable News (or relevant MedTech publication) • October 10, 2023
Acurable announced the appointment of Dr. Ramin Moshrefi as its new Chief Medical Officer. Dr. Moshrefi brings extensive experience in medical affairs and clinical development within the medical device industry and will spearhead Acurable's clinical strategy and physician engagement efforts....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Acurable, are just a search away.